Skip to main content
. 2019 Feb 27;24(5):840. doi: 10.3390/molecules24050840

Table 3.

Growth inhibition by compounds 36 against a panel of human tumor cell lines a.

Compound Cell Line (GI50 μM) b
HCT-15 NCI-H23 ACHN MDA-MB-231 NUGC-3 PC-3
3 8.2 7.1 8.0 7.3 6.5 8.1
4 25.0 26.2 26.2 23.2 14.9 24.7
5 8.1 7.8 7.4 7.3 7.9 8.8
6 >60 >60 >60 >60 >60 >60
Doxorubicin 0.2 0.1 0.1 0.1 0.1 0.2

a HCT-15, colon cancer; NCI-H23, lung cancer; ACHN, renal cancer; MDA-MB-231, breast cancer; NUGC-3, stomach cancer; PC-3, prostate cancer. b Data are an average of at least two tests.